✦ LIBER ✦

Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties

✍ Scribed by Martyn D. Wood; Claire Scott; Kirsten Clarke; Julie Westaway; Ceri H. Davies; Charlie Reavill; Mark Hill; Claire Rourke; Michael Newson; Declan N.C. Jones; Ian T. Forbes; Andrew Gribble

Book ID: 113586329
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 323 KB
Volume: 546
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2006.07.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.d.001 In-vitro pharmacology of aripi

P.3.d.001 In-vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors

✍ Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 96 KB

The clozapine metabolite N-desmethylcloz

The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D2 and serotonin 5-HT1A receptors

✍ Peter Heusler; Liesbeth Bruins Slot; Amélie Tourette; Stéphanie Tardif; Didier C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 536 KB

Discriminative stimulus properties of S3

Discriminative stimulus properties of S32504, a novel D3/D2receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox,N-desmethylclozapine, and by selective antagonists at dopamine D2but not D3receptors

✍ Mark J. Millan; Loretta Iob; Jean-Louis Péglion; Anne Dekeyne 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 345 KB